BREAKING
CF Industries Holdings, Inc. (CF) Drops 6.2% to $128.95 15 hours ago Vicor Corporation (VICR) Surges 11.6% to $158.83 15 hours ago Talos Energy Inc. (TALO) Drops 6.4% to $15.27 15 hours ago Hims & Hers Health, Inc. (HIMS) Jumps 8.6% to $20.41 15 hours ago BIO-key International, Inc. (BKYI) Q4 2025 Earnings Recap 15 hours ago Arrowhead Pharmaceuticals, Inc. (ARWR) Jumps 7.3% to $61.87 16 hours ago FactSet Research Systems Inc. (FDS) Q2 2026 Earnings Recap 16 hours ago Reading International, Inc. (RDI) Reports Q4 Earnings 16 hours ago Sunrun Inc. (RUN) Jumps 7.6% to $13.06 17 hours ago IMUNON 2025 Financial Review 17 hours ago CF Industries Holdings, Inc. (CF) Drops 6.2% to $128.95 15 hours ago Vicor Corporation (VICR) Surges 11.6% to $158.83 15 hours ago Talos Energy Inc. (TALO) Drops 6.4% to $15.27 15 hours ago Hims & Hers Health, Inc. (HIMS) Jumps 8.6% to $20.41 15 hours ago BIO-key International, Inc. (BKYI) Q4 2025 Earnings Recap 15 hours ago Arrowhead Pharmaceuticals, Inc. (ARWR) Jumps 7.3% to $61.87 16 hours ago FactSet Research Systems Inc. (FDS) Q2 2026 Earnings Recap 16 hours ago Reading International, Inc. (RDI) Reports Q4 Earnings 16 hours ago Sunrun Inc. (RUN) Jumps 7.6% to $13.06 17 hours ago IMUNON 2025 Financial Review 17 hours ago
ADVERTISEMENT
Earnings

Array Digital Infrastructure Inc (AD) reports strong earnings growth for Q4 2025

Array Digital Infrastructure Inc (AD) Misses Q4 2025 Earnings Estimates — EPS $-0.45 vs $0.30 Expected

February 19, 2026 1 min read

Array Digital Infrastructure Inc (AD) Misses Q4 2025 Earnings Estimates — EPS $-0.45 vs $0.30 Expected

BREAKING

Array Digital Infrastructure, Inc. (NYSE: AD) reported Q4 2025 earnings per share of $0.43, compared to $0.05 per share in the year-ago quarter.

Total operating revenues from continuing operations were $60.3 million in Q4.

The company closed its previously announced sale of 3.45GHz and 700MHz spectrum licenses to AT&T in January 2026

Full analysis with detailed breakdown coming shortly on AlphaStreet.

ADVERTISEMENT